Assessing the Role of Volumetric-modulated Arc Therapy in Hepatocellular Carcinoma

Overview

Journal J Appl Clin Med Phys

Specialties Biophysics
General Medicine

Date 2013 May 9

PMID 23652248

Citations 1

Authors

Mian Xi

Li Zhang

Qiao-Qiao Li

Lei Zhao

Rui Zhang

Meng-Zhong Liu

Affiliations

Soon will be listed here.

Abstract

The role of volumetric-modulated arc therapy (VMAT) in hepatocellular carcinoma (HCC) remains controversial. The purpose of this study was to determine the potential clinical role of VMAT compared with three-dimensional conformal radiotherapy (3D CRT) for liver irradiation. Four-dimensional CT scans of 24patients with unresectable HCC were included and divided into two groups: (1) adjacent group (n = 11), with planning target volumes overlapping or within 1 cm adjacent to the alimentary tract; (2) nonadjacent group (n = 13), in which the normal liver itself was the dose-limiting structure. Target coverage, organs-at-risk (OARs) doses, delivery parameters, and treatment accuracy were evaluated. Superior target coverage, conformity, and homogeneity were achieved with VMAT compared with 3D CRT. In the adjacent group, VMAT provided superior sparing of serial functioning OARs including the stomach, small intestine, and spinal cord. In the nonadjacent group, VMAT provided inferior sparing of most OARs including the liver, stomach, and small intestine. For the whole group, the effective treatment time was 2.1 ± 0.3 min for 3D CRT and 3.1 ± 0.2 min for VMAT. For liver lesions adjacent to the alimentary tract, this study indicates that VMAT should be selected due to the plan quality, delivery efficiency, and superior sparing of stomach and small intestine. However, for liver lesions away from the alimentary tract, VMAT is not superior to 3D CRT for normal tissue protection.

Citing Articles

Clinical application of real-time tumor-tracking for stereotactic volumetric modulated arc therapy for liver tumors.

Miyamoto N, Katoh N, Kanehira T, Yokokawa K, Suzuki R, Uchinami Y Phys Imaging Radiat Oncol. 2024; 31:100623.

PMID: 39224689 PMC: 11367098. DOI: 10.1016/j.phro.2024.100623.

References

Fotina I, Kragl G, Kroupa B, Trausmuth R, Georg D . Clinical comparison of dose calculation using the enhanced collapsed cone algorithm vs. a new Monte Carlo algorithm. Strahlenther Onkol. 2011; 187(7):433-41. DOI: 10.1007/s00066-011-2215-9. View

Cheng J, Wu J, Huang C, Liu H, Huang D, Tsai S . Dosimetric analysis and comparison of three-dimensional conformal radiotherapy and intensity-modulated radiation therapy for patients with hepatocellular carcinoma and radiation-induced liver disease. Int J Radiat Oncol Biol Phys. 2003; 56(1):229-34. DOI: 10.1016/s0360-3016(03)00091-9. View

Wolff D, Stieler F, Welzel G, Lorenz F, Abo-Madyan Y, Mai S . Volumetric modulated arc therapy (VMAT) vs. serial tomotherapy, step-and-shoot IMRT and 3D-conformal RT for treatment of prostate cancer. Radiother Oncol. 2009; 93(2):226-33. DOI: 10.1016/j.radonc.2009.08.011. View

Bedford J, Lee Y, Wai P, South C, Warrington A . Evaluation of the Delta4 phantom for IMRT and VMAT verification. Phys Med Biol. 2009; 54(9):N167-76. DOI: 10.1088/0031-9155/54/9/N04. View

Rao M, Wu J, Cao D, Wong T, Mehta V, Shepard D . Dosimetric impact of breathing motion in lung stereotactic body radiotherapy treatment using intensity modulated radiotherapy and volumetric modulated arc therapy [corrected]. Int J Radiat Oncol Biol Phys. 2012; 83(2):e251-6. DOI: 10.1016/j.ijrobp.2011.12.001. View

Yin Y, Ma C, Gao M, Chen J, Ma Y, Liu T . Dosimetric comparison of RapidArc with fixed gantry intensity-modulated radiotherapy treatment for multiple liver metastases radiotherapy. Med Dosim. 2011; 36(4):448-54. DOI: 10.1016/j.meddos.2010.12.001. View

Eccles C, Bissonnette J, Craig T, Taremi M, Wu X, Dawson L . Treatment planning study to determine potential benefit of intensity-modulated radiotherapy versus conformal radiotherapy for unresectable hepatic malignancies. Int J Radiat Oncol Biol Phys. 2008; 72(2):582-8. DOI: 10.1016/j.ijrobp.2008.06.1496. View

Murthy K, Shukeili K, Kumar S, Davis C, Chandran R, Namrata S . Evaluation of dose coverage to target volume and normal tissue sparing in the adjuvant radiotherapy of gastric cancers: 3D-CRT compared with dynamic IMRT. Biomed Imaging Interv J. 2011; 6(3):e29. PMC: 3097777. DOI: 10.2349/biij.6.3.e29. View

Kavanagh B, Pan C, Dawson L, Das S, Li X, Ten Haken R . Radiation dose-volume effects in the stomach and small bowel. Int J Radiat Oncol Biol Phys. 2010; 76(3 Suppl):S101-7. DOI: 10.1016/j.ijrobp.2009.05.071. View

10.

Palma D, Verbakel W, Otto K, Senan S . New developments in arc radiation therapy: a review. Cancer Treat Rev. 2010; 36(5):393-9. DOI: 10.1016/j.ctrv.2010.01.004. View

11.

Zhang L, Xi M, Deng X, Li Q, Huang X, Liu M . Four-dimensional CT-based evaluation of volumetric modulated arc therapy for abdominal lymph node metastasis from hepatocellular carcinoma. J Radiat Res. 2012; 53(5):769-76. PMC: 3430422. DOI: 10.1093/jrr/rrs022. View

12.

Xi M, Liu M, Deng X, Zhang L, Huang X, Liu H . Defining internal target volume (ITV) for hepatocellular carcinoma using four-dimensional CT. Radiother Oncol. 2007; 84(3):272-8. DOI: 10.1016/j.radonc.2007.07.021. View

13.

Takahashi W, Yamashita H, Saotome N, Iwai Y, Sakumi A, Haga A . Evaluation of heterogeneity dose distributions for Stereotactic Radiotherapy (SRT): comparison of commercially available Monte Carlo dose calculation with other algorithms. Radiat Oncol. 2012; 7:20. PMC: 3305645. DOI: 10.1186/1748-717X-7-20. View

14.

Kuo H, Mah D, Chuang K, Wu A, Hong L, Yaparpalvi R . A method incorporating 4DCT data for evaluating the dosimetric effects of respiratory motion in single-arc IMAT. Phys Med Biol. 2010; 55(12):3479-97. DOI: 10.1088/0031-9155/55/12/014. View

15.

Pan C, Kavanagh B, Dawson L, Li X, Das S, Miften M . Radiation-associated liver injury. Int J Radiat Oncol Biol Phys. 2010; 76(3 Suppl):S94-100. PMC: 4388033. DOI: 10.1016/j.ijrobp.2009.06.092. View

16.

Otto K . Volumetric modulated arc therapy: IMRT in a single gantry arc. Med Phys. 2008; 35(1):310-7. DOI: 10.1118/1.2818738. View

17.

Lee I, Seong J, Koom W, Kim Y, Jeon B, Kim J . Selection of the optimal radiotherapy technique for locally advanced hepatocellular carcinoma. Jpn J Clin Oncol. 2011; 41(7):882-9. DOI: 10.1093/jjco/hyr053. View

18.

Park J, Kim K, Chie E, Choi C, Ye S, Ha S . RapidArc vs intensity-modulated radiation therapy for hepatocellular carcinoma: a comparative planning study. Br J Radiol. 2012; 85(1015):e323-9. PMC: 3474061. DOI: 10.1259/bjr/19088580. View

19.

Dawson L, Normolle D, Balter J, McGinn C, Lawrence T, Ten Haken R . Analysis of radiation-induced liver disease using the Lyman NTCP model. Int J Radiat Oncol Biol Phys. 2002; 53(4):810-21. DOI: 10.1016/s0360-3016(02)02846-8. View

20.

Yovino S, Poppe M, Jabbour S, David V, Garofalo M, Pandya N . Intensity-modulated radiation therapy significantly improves acute gastrointestinal toxicity in pancreatic and ampullary cancers. Int J Radiat Oncol Biol Phys. 2010; 79(1):158-62. PMC: 10859038. DOI: 10.1016/j.ijrobp.2009.10.043. View